Insight

Diego Díaz-García: Targeted Protein Degradation is Reshaping Cancer Therapy

Diego A. Díaz-García/X

Aug 9, 2025, 17:36

Diego Díaz-García: Targeted Protein Degradation is Reshaping Cancer Therapy

Diego A. Díaz-García, Medical Oncologist, CEO, and Founder of CánCare – Advanced Oncology Specialty, shared a post on X about a paper by Matthias Hinterndorfer et al. published on the Nature Reviews Cancer:

“Targeted protein degradation is reshaping cancer therapy:

From PROTACs to molecular glues, new tools are enabling selective elimination of oncogenic proteins, with clinical impact on the horizon.”

Title: Targeted protein degradation for cancer therapy

Authors: Matthias Hinterndorfer, Valentina Spiteri, Alessio Ciulli, Georg Winter

You can read the Full Article on the Nature Reviews Cancer.

Diego Díaz-García: Targeted Protein Degradation is Reshaping Cancer Therapy

More posts featuring Cancer Therapy on OncoDaily.

Alessio Ciulli cancer Diego A. Díaz García Georg Winter Matthias Hinterndorfer Molecular glues OncoDaily Oncology PROTAC targeted therapy Valentina Spiteri

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...